Mid-Market Corporate Buyout Equity · Private Equity, VC & Investor
Greenoaks
Concentrated long-term venture investor in technology businesses.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Greenoaks Capital Partners, LLC
- Entity type
- COMPANY
- Founded
- 2012
- Headquarters
- 4 Orinda Way, Suite 200, Orinda, CA 94563
- Company size
- 10–49
- Market cluster / sector
- Mid-Market Corporate Buyout Equity
- Market role
- Private Equity, VC & Investor
- Official website
- greenoaks.com
What Greenoaks does
The firm raises pooled investment vehicles from limited partners and deploys that capital into a concentrated portfolio of private technology and internet-enabled companies. It creates value by sourcing high-conviction investments, supporting portfolio company growth over long holding periods, and realising returns through portfolio appreciation and exits. Its own economics are tied to managing external capital rather than selling software or media.
Category differentiation
Greenoaks is an investment firm, not a software vendor, adtech platform or operating technology company. It should be distinguished from portfolio companies it funds and from unrelated businesses using the Greenoaks name.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Greenoaks Capital Partners, LLC is a private investment firm headquartered in the United States that manages concentrated, long-term venture and growth investments in technology and internet-enabled businesses. The firm operates as an independent fund manager and partners with founders building large-scale software, internet and technology companies. Its customers are institutional limited partners allocating capital to venture and growth funds, and portfolio companies that receive capital and strategic support. Greenoaks generates revenue through fund management economics tied to assets under management, principally management fees and performance-based carried interest. The firm remains active and expanded its capital base with a $2.5 billion sixth venture fund closed in July 2025.
Company news briefing
Briefing updated:
Greenoaks has continued to scale its enterprise and AI portfolio, previously backing Safe Superintelligence alongside a $2 billion round, leading Simile's $200 million Series B at a $2 billion valuation, and supporting AI security startup AIR with a $40 million seed round. The firm also backed Superblocks in securing an AWS partnership for enterprise vibe-coding integration, and joined Altimeter in urging the U.S. Trade Representative to open a Section 301 probe regarding South Korea's regulatory actions toward Coupang.
Business model & monetisation
The firm monetises through investment fund economics: recurring management fees on committed or managed capital and carried interest on realised investment gains. Its commercial model is therefore fund-based rather than transactional, subscription software, advertising, or services-led.
- Fund management fees
- Service Fee
- Carried interest on investment gains
- Percentage Take-Rate
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Greenoaks
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Greenoaks's competitive landscape.
Private investment firm focused on technology and growth equity.
US venture capital firm backing private technology companies.
Global venture capital firm investing in technology companies.
Multi-stage venture capital firm investing in growth companies.
Venture capital firm backing fast-growing technology companies.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Coupang dispute raises U.S. tariff pressure on South Korea
Privacy · Recorded impact score: 3/5
A Republican-led House Judiciary report alleges the South Korean government mounted a targeted campaign against U.S.-headquartered Coupang after a 2025 data breach, prompting calls from some U.S. lawmakers and investors for formal trade investigations and potential tariffs. South Korea disputes the report, defends its actions and the scale of the breach, and says it has engaged with U.S. officials. Investors including Greenoaks and Altimeter urged the U.S. Trade Representative to open a Section 301 probe. The dispute comes amid broader U.S.-South Korea tensions over trade commitments, security cooperation and earlier tariff actions.
- House Judiciary Committee Republicans released a report alleging the South Korean government waged a targeted offensive against Coupang following a data breach.
- South Korea levied a 625 billion won (about $409 million) data-privacy fine on Coupang; Seoul says the breach affected 37.55 million people.
Simile AI: Behavioral Simulation and Scaling Laws
Behavioral simulation and synthetic populations for decision-making · Recorded impact score: 4/5
This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company's work building behavioral foundation models and synthetic populations for simulation. Simile has raised over $300 million at a $2 billion valuation, backed by a recent Series B. The company creates digital twins from interviews, transaction/observational data, and randomized controlled trials, enabling enterprise clients like CVS Health to test policies on simulated populations. In a 1,000-person study, digital twins reproduced human behavior about 85% as accurately as the originals. Simile has partnered with Gallup to access tens of millions of real human subjects, and aims to scale from market research and legal strategy to societal-level simulations of 'wicked problems' like climate change. The episode also discusses the company's multi-agent simulations and its long-term vision.
- Simile has raised over $300 million at a $2 billion valuation (reported Series B).
- Simile creates digital twins of real people from interviews and behavioral data, used by Fortune 100 clients like CVS.
Explore company relationships
Questions about Greenoaks
What is Greenoaks?
Greenoaks is a private venture and growth investment firm focused on concentrated, long-term investments in technology and internet-enabled businesses.
Who uses Greenoaks?
Its direct customers are institutional limited partners investing in its funds, while founders and management teams use Greenoaks as a long-term capital partner.
How does Greenoaks make money?
Greenoaks makes money through fund management fees and carried interest earned on successful investment outcomes.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
13 publicly documented primary sources and citations linked across the market graph.
Continue your research on Greenoaks
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals